<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-13T23:26:32Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.nprd.00106" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.nprd.00106</identifier>
    <datestamp>2026-04-14T10:47:29Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-04-14</dc:date>
  <dc:title>Preparation of pH-sensitive/folic acid-modified apigenin liposomes and its in vivo anti-tumor effect</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.nprd.00106</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>This study&amp;nbsp;aims to&amp;nbsp;construct&amp;nbsp;pH-sensitive/folic acid-modified apigenin&amp;nbsp;liposomes (pH/FA-Api-Lips),&amp;nbsp;and&amp;nbsp;to&amp;nbsp;conduct&amp;nbsp;pharmacokinetics, tissue distribution and&amp;nbsp;in vivo&amp;nbsp;anti-tumor evaluation. pH/FA-Api-Lips were prepared by film-hydration method, and its&amp;nbsp;physicochemical properties were characterized. Drug release behavior of pH/FA-Api-Lips in phosphate buffer saline solution with different pH values was investigated. HepG2 cells were&amp;nbsp;used to establish the hepatoma-bearing mice model, apigenin and pH/FA-Api-Lips were intravenously injected to the hepatoma-bearing mice at dose of 20 mg/kg. The pharmacokinetics, tissue distribution and anti-tumor effects of pH/FA-Api-Lips in vivo&amp;nbsp;were also investigated. The results showed that average envelopment efficiency, drug loading, particle size&amp;nbsp;and Zeta potential were 92.26%&amp;nbsp;&amp;plusmn;&amp;nbsp;1.72%, 7.49%&amp;nbsp;&amp;plusmn;&amp;nbsp;0.18%, 212.69&amp;nbsp;&amp;plusmn;&amp;nbsp;7.07 nm and &amp;ndash; 21.27&amp;nbsp;&amp;plusmn;&amp;nbsp;0.59 mV, respectively. The appearance of pH/FA-Api-Lips was vesicular, and the in vitro&amp;nbsp;drug release exhibited&amp;nbsp;obvious pH-sensitivity.&amp;nbsp;pH/FA-Api-Lips enhanced the bioavailability of apigenin, the relative uptake efficiency and peak concentration ratio of apigenin in tumor tissue was increased by 2.64-fold and 1.82-fold, respectively. The results of the pharmacological experiments in vivo&amp;nbsp;showed that pH/FA-Api-Lips significantly inhibited the tumor volume growth in hepatoma-bearing mice, and there was no significant decrease in body weight. pH/FA-Api-Lips increased the tumor inhibition rate of apigenin from 26.76% to 66.67%. Therefore, pH/FA-Api-Lips improved the tumor targeting of apigenin in vivo, and enhanced the anti-tumor efficacy. pH/FA-Api-Lips had the potential to be developed into an anti-tumor drug.&amp;nbsp;</dc:description>
  <dc:subject>apigenin; pH-sensitive; folic acid-modified; liposomes; anti-tumor</dc:subject>
  <dc:creator>cui xiao ge</dc:creator>
  <dc:creator>Li Fang</dc:creator>
  <dc:creator>Wang Yinghui</dc:creator>
  <dc:rights>EMBARGO</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>